Sabra Health Care remains a Buy, supported by strong SHOP expansion, robust guidance, and a sustainable 5.84% dividend yield. Click to read why SBRA is a Buy.

A number of popular car brands in Australia are at risk of paying fines in excess of $10 million for not meeting tightening ...

Indonesia sits at the centre of Southeast Asia’s growth story, writes Mary Veronika, Indonesia Country Manager, Intralink. As ...

Good morning, everyone, and welcome to NIQ's fourth quarter and full year 2025 earnings call. Joining me today are CEO, Jim Peck; CFO, Mike Burwell; and Chief Product Officer, Troy Treangen. Following ...

Middlesbrough released their latest accounts on Friday morning, which covers the 12-month period up to June, 2025 ...

Q4 2025 Management View CEO Peter Anevski reported, “2025 was an exceptionally strong year for Progyny where we achieved record highs in revenue and adjusted EBITDA, with both metrics increasing ...

This study provides important insights into how working memory shapes perceptual decisions, using a dual-task design, continuous mouse tracking, and hierarchical Bayesian modeling. By dissociating ...

Highlights Firm commitments received for Placement raising A$4 million Strongly supported by multiple new domestic and international institutional investors Placement price of A$1.05 per share ...

Target Corp. is moving quickly to simplify its structure so it can advance its strategy with speed. Cara Sylvester was named chief merchant.

Novavax (NASDAQ:NVAX) executives told investors the company made “significant progress” in 2025 executing a strategy centered ...

Investors who want to sleep easier often gravitate toward safe, reliable companies that you can buy and forget while earning quarterly passive income. Blue chip stocks are shares in the markets' most ...